SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000944809-22-000029
Filing Date
2022-05-13
Accepted
2022-05-13 16:17:20
Documents
18
Period of Report
2022-05-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K opk-20220509.htm   iXBRL 8-K 77641
2 EX-2.1 a8-kmodexex21.htm EX-2.1 716962
3 EX-10.1 a8-kmodexex101.htm EX-10.1 88433
4 EX-10.2 a8-kmodexex102.htm EX-10.2 33465
5 EX-10.3 a8-kmodexex103.htm EX-10.3 34215
9 GRAPHIC image_0.jpg GRAPHIC 60877
10 GRAPHIC image_0a.jpg GRAPHIC 60877
  Complete submission text file 0000944809-22-000029.txt   1416388

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opk-20220509.xsd EX-101.SCH 1929
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opk-20220509_lab.xml EX-101.LAB 24137
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opk-20220509_pre.xml EX-101.PRE 12538
12 EXTRACTED XBRL INSTANCE DOCUMENT opk-20220509_htm.xml XML 10812
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 22922955
SIC: 2834 Pharmaceutical Preparations